WuXi PharmaTech (Cayman) Inc. (CIK: 0001403132) EDGAR, Information, Filings... CompaniesBIO.Com

WuXi PharmaTech (Cayman) Inc.

Mailing address
288 FUTE ZHONG ROAD, WAIGAOQIAO FREE TRADE ZONE, SHANGHAI, Cayman Islands, 200131
Phone
86-21-5046-1111
State location
China
State of incorporation
Cayman Islands
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

WuXi PharmaTech (Cayman) Inc. (CIK: 0001403132) is an American company incorporated in the state of China. Head office is located at 288 FUTE ZHONG ROAD, WAIGAOQIAO FREE TRADE ZONE, SHANGHAI, China, 200131. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. WuXi PharmaTech (Cayman) Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by WuXi PharmaTech (Cayman) Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
CT ORDER	Document	Acc-no: 9999999997-17-008433 (33 Act) Size: 13 KB	Aug-31-2017	001-33623 171064019
CT ORDER	Document	Acc-no: 9999999997-17-005838 (33 Act) Size: 10 KB	May-01-2017	333-144806 17799208
CT ORDER	Document	Acc-no: 9999999997-16-023148 (33 Act) Size: 10 KB	May-24-2016	333-144806 161671114
CT ORDER	Document	Acc-no: 9999999997-16-023147 (33 Act) Size: 10 KB	May-24-2016	333-144806 161671111
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-16-051283 (34 Act) Size: 124 KB	Feb-10-2016	005-83350 161403563
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902219-16-000621 (34 Act) Size: 24 KB	Jan-11-2016	005-83350 161335437
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-15-408300 (34 Act) Size: 10 KB	Dec-21-2015	001-33623 151298159
25-NSE	Document	Acc-no: 0000876661-15-000627 (34 Act) Size: 4 KB	Dec-11-2015	001-33623 151282880
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-15-400331 (33 Act) Size: 20 KB	Dec-10-2015	333-182917 151281536
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-15-400317 (33 Act) Size: 21 KB	Dec-10-2015	333-146730 151281511
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-15-400299 (34 Act) Size: 20 KB	Dec-10-2015	001-33623 151281462
SC 13E3/A	Document	Amendment to Schedule filed to report going private transactions Acc-no: 0001193125-15-400259 (34 Act) Size: 75 KB	Dec-10-2015	005-83350 151281321
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902219-15-000607 (34 Act) Size: 32 KB	Dec-10-2015	005-83350 151280479
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-15-387711 (34 Act) Size: 18 KB	Nov-25-2015	001-33623 151254395
SC 13E3/A	Document	Amendment to Schedule filed to report going private transactions Acc-no: 0001193125-15-383021 (34 Act) Size: 8894 KB	Nov-20-2015	005-83350 151245150
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-15-374523 (34 Act) Size: 20 KB	Nov-12-2015	001-33623 151221248
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-15-364347 (34 Act) Size: 5201 KB	Nov-03-2015	001-33623 151194003
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-15-347776 (34 Act) Size: 21 KB	Oct-20-2015	001-33623 151165682
SC 13E3/A	Document	Amendment to Schedule filed to report going private transactions Acc-no: 0001193125-15-347709 (34 Act) Size: 2753 KB	Oct-20-2015	005-83350 151165574
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001193125-15-340772 ( Act) Size: 26 KB	Oct-09-2015

Recent 20 filings. View all WuXi PharmaTech (Cayman) Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

WuXi PharmaTech (Cayman) Inc. overview
WuXi PharmaTech (Cayman) Inc. job
WuXi PharmaTech (Cayman) Inc. stock
WuXi PharmaTech (Cayman) Inc. ownership
WuXi PharmaTech (Cayman) Inc. CEO
WuXi PharmaTech (Cayman) Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.